Privia Health Group Statistics
Share Statistics
Privia Health Group has 120.00M shares outstanding. The number of shares has increased by 1.27% in one year.
Shares Outstanding | 120.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.21% |
Owned by Institutions (%) | n/a |
Shares Floating | 106.24M |
Failed to Deliver (FTD) Shares | 1.25K |
FTD / Avg. Volume | 0.17% |
Short Selling Information
The latest short interest is 5.62M, so 4.68% of the outstanding shares have been sold short.
Short Interest | 5.62M |
Short % of Shares Out | 4.68% |
Short % of Float | 5.29% |
Short Ratio (days to cover) | 8.39 |
Valuation Ratios
The PE ratio is 116.48 and the forward PE ratio is 86.85. Privia Health Group 's PEG ratio is 1.46.
PE Ratio | 116.48 |
Forward PE | 86.85 |
PS Ratio | 1.62 |
Forward PS | 1.3 |
PB Ratio | 4.79 |
P/FCF Ratio | 33.32 |
PEG Ratio | 1.46 |
Enterprise Valuation
Privia Health Group Inc. has an Enterprise Value (EV) of 2.31B.
EV / Earnings | 99.97 |
EV / Sales | 1.39 |
EV / EBITDA | 84.88 |
EV / EBIT | 111.73 |
EV / FCF | 28.6 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.01.
Current Ratio | 1.81 |
Quick Ratio | 1.81 |
Debt / Equity | 0.01 |
Total Debt / Capitalization | 0.54 |
Cash Flow / Debt | 26.55 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.04% and return on capital (ROIC) is 2.43%.
Return on Equity (ROE) | 0.04% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 2.43% |
Revenue Per Employee | 1.50M |
Profits Per Employee | 20.94K |
Employee Count | 1.10K |
Asset Turnover | 1.66 |
Inventory Turnover | 0 |
Taxes
Income Tax | 7.99M |
Effective Tax Rate | 0.28 |
Stock Price Statistics
The stock price has increased by -7.14% in the last 52 weeks. The beta is 0.76, so Privia Health Group 's price volatility has been higher than the market average.
Beta | 0.76 |
52-Week Price Change | -7.14% |
50-Day Moving Average | 19.8 |
200-Day Moving Average | 19 |
Relative Strength Index (RSI) | 48.99 |
Average Volume (20 Days) | 732.55K |
Income Statement
In the last 12 months, Privia Health Group had revenue of $1.66B and earned $23.08M in profits. Earnings per share was $0.2.
Revenue | 1.66B |
Gross Profit | 161.50M |
Operating Income | 20.65M |
Net Income | 23.08M |
EBITDA | 27.18M |
EBIT | 20.65M |
Earnings Per Share (EPS) | 0.2 |
Balance Sheet
The company has $389.51M in cash and $8.29M in debt, giving a net cash position of $381.22M.
Cash & Cash Equivalents | 389.51M |
Total Debt | 8.29M |
Net Cash | 381.22M |
Retained Earnings | -193.61M |
Total Assets | 1.15B |
Working Capital | 374.28M |
Cash Flow
In the last 12 months, operating cash flow was $80.78M and capital expenditures -$113.00K, giving a free cash flow of $80.67M.
Operating Cash Flow | 80.78M |
Capital Expenditures | -113.00K |
Free Cash Flow | 80.67M |
FCF Per Share | 0.69 |
Margins
Gross margin is 9.74%, with operating and profit margins of 1.25% and 1.39%.
Gross Margin | 9.74% |
Operating Margin | 1.25% |
Pretax Margin | 1.75% |
Profit Margin | 1.39% |
EBITDA Margin | 1.64% |
EBIT Margin | 1.25% |
FCF Margin | 4.87% |
Dividends & Yields
PRVA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 0.96% |
FCF Yield | 3.21% |
Analyst Forecast
The average price target for PRVA is $25, which is 19.4% higher than the current price. The consensus rating is "Buy".
Price Target | $25 |
Price Target Difference | 19.4% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Scores
Altman Z-Score | 4.82 |
Piotroski F-Score | 6 |